A father and his young daughter sitting on a couch and looking at a tablet

TZIELD COMPASS SUPPORT PROGRAM

A TZIELD COMPASS Navigator is ready to help

Through our personalized program, a COMPASS Navigator can connect you with tools and resources, information on financial assistance options, and one-on-one support from the day you are enrolled. This means you can get the help you need, when you need it to support you during the treatment process.

TZIELD COMPASS Navigators are here to help with:

A clipboard

Personalized Support

TZIELD COMPASS Navigators can answer questions about the program and resources, including how your insurance benefits work, and help you determine your out-of-pocket costs

A dollar sign

TZIELD Copay Program

Navigators can provide information about the TZIELD Copay Program,*
where eligible commercially insured patients may pay as little as $0, and help you explore other financial assistance options that may be available to you

A location pin

Treatment Information

Navigators can help you understand where to get TZIELD infusions depending on your insurance and other factors, plus check in with you once treatment is completed

Two young women smilingActor Portrayal

Get started

Download the TZIELD COMPASS start form

For more information about TZIELD COMPASS Support, call 1-844-778-2246 Monday through Friday, 8 am-8 pm ET.

Katie's TZIELD® (teplizumab-mzwv) type 1 diabetes patient story video

Katie’s Journey

Katie’s path through diagnosis and to TZIELD was full of twists and turns. But Katie is not the type of woman who lets anything keep her from where she wants to go. Watch how her determination, and the help of a TZIELD COMPASS Navigator, helped her manage type 1 diabetes on her terms.

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Officiis illo ex praesentium amet tenetur? Doloremque asperiores, quo repudiandae fugit alias reiciendis libero maxime quis, unde dolorem voluptate error vel explicabo?

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Officiis illo ex praesentium amet tenetur? Doloremque asperiores, quo repudiandae fugit alias reiciendis libero maxime quis, unde dolorem voluptate error vel explicabo?

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Officiis illo ex praesentium amet tenetur? Doloremque asperiores, quo repudiandae fugit alias reiciendis libero maxime quis, unde dolorem voluptate error vel explicabo?

TZIELD COMPASS is a patient support program that helps eligible patients to gain access to TZIELD and provides them with education and resources related to TZIELD.

This program is intended to help with the cost of TZIELD and its infusion administration only. It does not help with the cost of other medicines you take at the same time as TZIELD or with other facility fees. Not valid for prescriptions paid, in whole or in part, by Medicaid, Medicare, VA, DOD, TRICARE, or other federal or state programs including any stat pharmaceutical assistance programs. Eligibility requirements and terms and conditions apply. See here for more information on the terms and conditions.

HOW TO GET STARTED WITH

TZIELD COMPASS logo

After you or your loved one has been prescribed TZIELD, enroll in TZIELD COMPASS in three steps:


Step 1:

Complete the START Form with your doctor

Step 2:

Your doctor will submit the completed form

Step 3:

Once enrolled, a COMPASS Navigator will give you a phone call within 1 business day from the TZIELD COMPASS Support Program

IMPORTANT SAFETY INFORMATION What is the most important information I should know about TZIELD? TZIELD may cause serious side effects. These include:
  • Cytokine release syndrome (CRS). Signs and symptoms may start during the first 5 days of TZIELD treatment and could include fever, nausea, feeling tired (fatigue), headache, muscle and joint pain, or increased liver enzymes in your blood. Tell your healthcare provider right away if you develop any signs and symptoms of CRS during treatment with TZIELD
  • Decrease in white blood cells. TZIELD may cause a decrease in a type of white blood cell called lymphocytes. A decrease in white blood cells is a serious, but common side effect that can affect your body’s ability to fight infections. A decrease in white blood cell counts can happen after your first dose. Your white blood cell counts will start to go back to normal after your fifth dose of TZIELD. Some people may develop longer and more severe decreases in lymphocytes

Your healthcare provider will do blood tests to check your liver and your complete blood counts before you start treatment and during treatment with TZIELD. During and after your treatment with TZIELD, your healthcare provider will check for serious side effects, as well as other side effects, and treat you as needed. Your healthcare provider may temporarily or completely stop your treatment with TZIELD, if you develop liver problems, have a serious infection, or if your blood counts stay too low.

What should I tell my healthcare provider before receiving TZIELD? Before or after receiving TZIELD, tell your healthcare provider about all your medical conditions, including if you:
  • have a serious infection or an infection that does not go away or keeps coming back
  • have recently received or are scheduled to receive an immunization (vaccine). TZIELD may affect how well a vaccine works. Tell your doctor that you are receiving TZIELD before receiving a vaccine
  • are pregnant or plan to become pregnant. TZIELD may harm your unborn baby. Do not receive TZIELD during pregnancy and at least 30 days before a planned pregnancy
  • are breastfeeding or plan to breastfeed. It is not known if TZIELD passes into your breast milk and if it can harm your baby. Talk to your healthcare provider about the best way to feed your baby if you receive TZIELD

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of TZIELD? The most common side effects of TZIELD include:
  • rash
  • leukopenia (decrease in white blood cell counts)
  • headache

These are not all of the possible side effects of TZIELD. Talk to your healthcare provider for more information, and tell them about any side effects you notice. You may report side effects to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.

Please see Medication Guide and Prescribing Information.

What is TZIELD?

TZIELD is a prescription medicine used to delay the onset of Stage 3 type 1 diabetes, which is when your body can’t make enough insulin on its own and may require insulin injections. TZIELD is for adults and children 8 years of age and older who have Stage 2 type 1 diabetes. This means that they have tested positive for 2 or more type 1 diabetes-related autoantibodies, have abnormal blood sugar levels, and do not have type 2 diabetes.

It is not known if TZIELD is safe and effective in children under 8 years of age.

IMPORTANT SAFETY INFORMATION AND APPROVED USE

What is the most important information I should know about TZIELD? TZIELD may cause serious side effects. These include:
  • Cytokine release syndrome (CRS). Signs and symptoms may start during the first 5 days of TZIELD treatment and could include fever, nausea, feeling tired (fatigue), headache, muscle and joint pain, or increased liver enzymes in your blood. Tell your healthcare provider right away if you develop any signs and symptoms of CRS during treatment with TZIELD
  • Decrease in white blood cells. TZIELD may cause a decrease in a type of white blood cell called lymphocytes. A decrease in white blood cells is a serious, but common side effect that can affect your body’s ability to fight infections. A decrease in white blood cell counts can happen after your first dose. Your white blood cell counts will start to go back to normal after your fifth dose of TZIELD. Some people may develop longer and more severe decreases in lymphocytes

Your healthcare provider will do blood tests to check your liver and your complete blood counts before you start treatment and during treatment with TZIELD. During and after your treatment with TZIELD, your healthcare provider will check for serious side effects, as well as other side effects, and treat you as needed. Your healthcare provider may temporarily or completely stop your treatment with TZIELD, if you develop liver problems, have a serious infection, or if your blood counts stay too low.

What should I tell my healthcare provider before receiving TZIELD? Before or after receiving TZIELD, tell your healthcare provider about all your medical conditions, including if you:
  • have a serious infection or an infection that does not go away or keeps coming back
  • have recently received or are scheduled to receive an immunization (vaccine). TZIELD may affect how well a vaccine works. Tell your doctor that you are receiving TZIELD before receiving a vaccine
  • are pregnant or plan to become pregnant. TZIELD may harm your unborn baby. Do not receive TZIELD during pregnancy and at least 30 days before a planned pregnancy
  • are breastfeeding or plan to breastfeed. It is not known if TZIELD passes into your breast milk and if it can harm your baby. Talk to your healthcare provider about the best way to feed your baby if you receive TZIELD

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of TZIELD? The most common side effects of TZIELD include:
  • rash
  • leukopenia (decrease in white blood cell counts)
  • headache

These are not all of the possible side effects of TZIELD. Talk to your healthcare provider for more information, and tell them about any side effects you notice. You may report side effects to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.

Please see Medication Guide and Prescribing Information.

What is TZIELD?

TZIELD is a prescription medicine used to delay the onset of Stage 3 type 1 diabetes, which is when your body can’t make enough insulin on its own and may require insulin injections. TZIELD is for adults and children 8 years of age and older who have Stage 2 type 1 diabetes. This means that they have tested positive for 2 or more type 1 diabetes-related autoantibodies, have abnormal blood sugar levels, and do not have type 2 diabetes.

It is not known if TZIELD is safe and effective in children under 8 years of age.